ADMA Biologics Inc (ADMA) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the ADMA Biologics Second Quarter twenty twenty six Financial Results and Business Update Conference Call on Wednesday, 08/05/2026. At this time, all participants are in a listen only mode. There will be a question and answer session to follow. Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call. At this time, I would like to introduce the company. Please go ahead. Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the second quarter of twenty twenty six and recent corporate updates. I'm joined today by Adam Grossman, our president and chief executive officer Terry Kohler, our chief financial officer and treasurer. During today's call, Adam will provide some introductory comments and provide an update on corporate progress, and Terry will provide an overview of the company's second quarter twenty twenty six financial results. Finally, Adam will then provide some brief summary remarks before opening up the call for questions. Earlier today, we issued a press release detailing the second quarter twenty twenty six financial results and summarized certain achievements and recent corporate updates. The release is available on our website at www.abnobiologics.com. Before we begin our formal comments, I'll remind you that we will be making forward looking statements during today's call that represent the company's intentions, expectations, or beliefs concerning future events, which constitute forward looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. All forward looking statements are su...